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The specificity of the heme-regulated protein kinase (HRI) was investigated further by utilizing the isolated 
38000 Da subunit (a subunit) polypeptide of eIF-2 as the substrate. For this purpose, the three subunit 
polypeptides of eIF-2 (38000 Da, a; 50000 Da, /3; and 52000 Da, y) were resolved by reversed-phase high 
performance liquid chromatography (HPLC). Results show that HRI is incapable of phosphorylating the 
38000 Da subunit separated from the other two eIF-2 polypeptides. Data suggest hat the substrate’spccific- 
ity of HRI is determined by the quaternary structure assumed by the c( subunit in association with the other 
two subunits in the eIF-2 holoprotein. 
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1. INTRODUCTION 
Protein synthesis in rabbit reticulocytes and 
their lysates is regulated by heme (reviews [l-3]). 
In heme deficiency, a heme-regulated translational 
inhibitor (HRI) is activated that blocks protein 
chain initiation. A second translational inhibitor in 
lysates is activated by low concentrations of 
double-stranded RNA [4]. The HRI and double- 
stranded RNA-activated inhibitors have been iden- 
tified as adenosine 3 ’ : 5 ’ cyclic-monophosphate 
independent protein kinases (eIF-2 protein kinases) 
that specifically phosphorylate the same site on the 
38 kDa subunit (a subunit) of initiation factor 
eIF-2 [5-141. As a consequence, catalytic reutiliza- 
tion of initiation factor eIF-2 is inhibited [ 15-241. 
eIF-2 promotes formation of the ternary complex 
(eIF-2. GTP . Met-tRNAf), the first rate limiting 
reaction in the protein synthesis initiation cycle. 
* To whom correspondence should be addressed 
Unlike CAMP-dependent protein kinases, which 
phosphorylate a wide spectrum of substrates [25], 
HRI-catalyzed phosphorylation is highly specific 
and is restricted to eIF-2 [5-81. It is not known 
whether this specificity of phosphorylation resides 
in the eIF-2 holoenzyme or if HRI is capable of 
phosphorylating the 38 kDa subunit free of the 
other two eIF-2 subunit polypeptides (the 50 kDa 
u subunit) and the 52 kDa (y subunit) polypep- 
tides). In order to examine this question, the three 
eIF-2 subunits were separated by reversed-phase 
high performance liquid chromatography (HPLC). 
The phosphorylation of the isolated eIF-2 38 kDa 
subunit by purified HRI was assayed. The results 
presented in this communication show that HRI is 
not able to phosphorylate the isolated 38 kDa 
subunit of eIF-2. 
2. EXPERIMENTAL 
The following procedures have been described: 
preparation of purified initiation factor eIF-2; 
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preparation of purified HRI (spec. act. 5000 units 
per mg); SDS-polyacrylamide gel electrophoresis; 
eIF-2 phosphorylation assay; and autoradiography 
of polyacrylamide gels [26]. 
2.1. Separation of elF-2 subunits by high 
performance liquid chromatography 
Pure eIF-2 (4Opg) was suspended in 20% 
acetonitrile (ACN) buffered with 0.05% 
trifluoroacetic acid (TFA) and applied to a Baker 
Bond reversed-phase wide pore (330 A) CS column 
(4.8 x 250 mm) pre-equilibrated with 40% ACN 
buffered with 0.1% TFA [27]. The polypeptides 
were then eluted with a 40-60% ACN gradient 
buffered with 0.1% TFA. The gradient was 
delivered over a period of 40 min at a flow rate of 
0.5 ml/min. The eluent was monitored at 220 nm, 
with a signal input to the recorder of 100 mV and 
a sensitivity of 0.05 absorption units full scale. The 
eluent from the column was collected in 0.25 ml 
fractions and the polypeptides eluted from the col- 
umn were identified by electrophoresis in SDS- 
polyacrylamide gel (10%) along with l-2 pg of 
standard eIF-2 holoenzyme. The proteins in the gel 
were stained with Coomassie brilliant blue dye. 
The fractions containing the 38 kDa subunit 
were lyophilized and resuspended in protein 
phosphorylation mixture (20 mM Tris-HCI, pH 
7.6; 60 mM KCl; 1 mM dithiothreitol; 5 mM 
magnesium acetate and 0.2 mM [y-32P]ATP, spec. 
act. 6000 cpm/mmol). The protein phosphoryla- 
tion was assayed after the addition of HRI as 
described [26]. 
3. RESULTS AND DISCUSSION 
The results in fig.1 show the resolution of the 
three subunit polypeptides of eIF-2 by 
chromatography on a CS wide pore HPLC column. 
A comparison of these polypeptides and standard 
eIF-2 polypeptides upon electrophoresis in SDS- 
polyacrylamide gels identified the 6 min retention 
time fraction polypeptide as the 50 kDa subunit, 
the 38 min retention time peak as the 38 kDa 
polypeptide and the 42.5 min retention time peak 
as the 52 kDa polypeptide. 
The separated 38 kDa subunit polypeptide was 
dried under vacuum. To determine if the separated 
subunit could be phosphorylated by HRI, aliquots 
of eIF-2 phosphorylation reaction mixture and 
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Fig.1. Separation of eIF-2 polypeptides by reversed 
phase HPLC. Details are provided in section 2. 
i 
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Fig.2. Phosphorylation of eIF-2 and isolated 38kDa 
eIF-2 polypeptide by HRI. eIF-2 holoenzyme or the 
38 kDa polypeptide was incubated with HRI under the 
phosphorylation reaction conditions described in section 
2 [26]. After 1 h incubation at 3O”C, the reaction was 
terminated by the addition of denaturing solution and 
the mixture heated at 100°C for several minutes. 
Samples were subjected to electrophoresis in SDS- 
polyacrylamide gel (10%). The proteins in the gel were 
stained with Coomassie brilliant blue dye (left) and then 
autoradiographed (right). Lanes: 1, eIF-2 holoprotein 
(1 pg) + HRI (0.05 pg); 2, eIF-2 38kDa polypeptide 
(0.25 pg) + HRI (0.05 cg). The position of the 38kDa 
subunit is indicated. 
HRI were mixed with the 38 kDa polypeptide. 
Samples were incubated at 30°C for 1 h and 
analyzed by SDS-polyacrylamide gel elec- 
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trophoresis. Results are presented in fig.2. Under 
these conditions, no detectable phosphorylation of 
the 38 kDa subunit was observed (fig.2). These 
results would suggest that HRI is incapable of 
phosphorylating the 38 kDa subunit when 
separated from the other subunits. Consequently, 
the specificity of 38 kDa subunit phosphorylation 
by HRI is determined by the quaternary structure 
of the holoenzyme (assumed by the CY subunit in 
association with the other subunits). When this 
structure is disrupted, HRI is unable to 
phosphorylate the eIF-2 LY subunit. 
In an earlier study, this laboratory [28,29] 
showed that a specific site on the 38 kDa subunit 
is phosphorylated by eIF-2 protein kinases ir- 
respective of the source of these enzymes. This 
would suggest hat the eIF-2 site phosphorylated 
by such protein kinases is not only unique but is 
also highly conserved. Recently, Wettenhall et al. 
[30] have sequenced the phosphopeptide of the 
38 kDa subunit phosphorylated by HRI. Consis- 
tent with the high specificity of HRI-catalyzed 
eIF-2 phosphorylation, this phosphopeptide ex- 
hibits a unique sequence 
(Arg-Ile-Leu-Leu-Ser4*-Glu-Leu-Se?’-Arg) [30]. 
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